OSPN (OSPN)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9, Altman Z 3.9. Beneish M-Score of -2.08 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe company exhibits a precarious capital efficiency profile, where the ROIC of 14.0% barely outpaces the WACC by only 0.1%, indicating that value creation is marginal and highly sensitive to minor shifts in cost of capital or return rates. Despite this narrow spread, profitability metrics remain robust with net margins at 30.0% and gross margins near 74%, suggesting strong pricing power; however, revenue growth has stagnated completely year-over-year, raising questions about the sustainability of these high margins without top-line expansion. Financial health indicators present a mixed signal: while the Beneish M-Score of -2.08 suggests low earnings manipulation risk and the Altman Z-Score of 3.9 indicates a safe distance from bankruptcy, the Piotroski F-Score of 5/9 reflects moderate fundamental strength that lacks the defensive characteristics of high-quality compounders.
Valuation metrics appear deeply compressed relative to historical norms and sector peers, with a current P/E ratio of 5.7x implying significant market skepticism regarding future earnings visibility. This discount aligns closely with a DCF-derived fair value estimate of $16, which likely assumes conservative growth trajectories given the zero revenue expansion observed recently. The market appears to be pricing in substantial downside risk related to stagnation rather than intrinsic undervaluation based on current profitability alone, creating a scenario where the low multiple may persist until there is demonstrable evidence of operational revitalization or margin defense against inflationary pressures.
Risk assessment reveals an asymmetric setup driven primarily by growth decoupling from profits; while the balance sheet remains intact as indicated by the Altman score, the lack of revenue momentum combined with minimal ROIC-WACC spread limits the upside potential for alpha generation under standard Fama-French factors unless leverage increases significantly to boost returns. The absence of insider activity data in this dataset prevents a definitive conclusion on management alignment, but the fundamental disconnect between high margins and flat sales suggests that any future catalyst must come from renewed top-line velocity rather than operational efficiency gains alone.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 11.9% | 13.9% | 15.9% |
|---|---|---|---|
| 2% | $18 | $15 | $13 |
| 3% | $19 | $16 | $13 |
| 4% | $21 | $17 | $14 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=13.9%, terminal growth 3%. Fair value $16 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XSW or VFVA, the fund manager is mechanically forced to buy or sell OSPN shares regardless of OSPN's individual fundamentals. We estimate $17M of passive capital is structurally linked to OSPN through 4 tracked ETFs. Passive flows have a limited but growing influence on OSPN's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 4 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in OSPN to visualize passive redemption contagion across ETFs and collateral stocks.
If OSPN (OSPN) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NVIDIA Corp. (NVDA) as the most exposed collateral stock, sharing 2 ETFs with OSPN. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 4 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
OSPN Ownership Dynamics
ETFs with Highest OSPN Exposure
Float lock-up computed from 4 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
OSPN Capital Efficiency
How efficiently does OSPN convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
OSPN converts 84% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 0.1% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 39,437 | $11.95 | $471,272.15 |
| 2026-05-01 | 596 | $11.58 | $6,901.68 |
| 2026-04-27 | 273 | $11.34 | $3,095.82 |
| 2026-04-02 | 412 | $10.61 | $4,371.32 |
| 2026-04-01 | 412 | $10.53 | $4,338.36 |
| 2026-03-23 | 912 | $10.41 | $9,493.92 |
| 2026-02-27 | 4,296 | $11.37 | $48,845.52 |
| 2026-02-26 | 386 | $11.14 | $4,300.04 |
| 2026-02-23 | 3 | $11.38 | $34.14 |
| 2026-02-13 | 62 | $10.80 | $669.6 |
| 2025-12-22 | 100 | $12.78 | $1,278 |
| 2025-11-03 | 60 | $11.40 | $684 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare OSPN to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.